[1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
|
[2] |
Park JW, Chen M, Colombo M, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE study[J]. Liver Int, 2015, 35(9):2155-2166.
|
[3] |
Shi F, Lian S, Mai Q, et al. Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria[J]. Eur Radiol, 2020, 30(5):2454-2462.
|
[4] |
Affonso BB, Galastri FL, da Motta Leal Filho JM, et al. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging[J]. World J Gastroenterol, 2019, 25(37):5687-5701.
|
[5] |
Hamaoka M, Kobayashi T, Kuroda S, et al. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: a retrospective cohort study[J]. Int J Surg, 2017(44):223-228.
|
[6] |
Galle PR, Tovoli F, Foerster F, et al. The treatment of intermediate stage tumours beyond TACE: from surgery to systemic therapy[J]. J Hepatol, 2017, 67(1):173-183.
|
[7] |
方驰华, 张鹏, 周伟平,等. 三维可视化技术用于1 665例原发性肝癌精准诊治的多中心回顾性研究[J]. 中华外科杂志, 2020, 58(5):375-382.
|
[8] |
Fang C, An J, Bruno A, et al. Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases[J]. Hepatol Int, 2020, 14(4):437-453.
|
[9] |
Rhu J, Kim MS, Kim S, et al. Application of three-dimensional printing for intraoperative guidance during liver resection ofa hepatocellular carcinoma with sophisticated location[J]. Ann Hepatobiliary Pancreat Surg, 2021, 25(2):265-269.
|
[10] |
Igami T, Nakamura Y, Oda M, et al. Application of three-dimensional print in minor hepatectomy following liver partition between anterior and posterior sectors[J]. ANZ J Surg, 2018, 88(9):882-885.
|
[11] |
陈攀, 谢威, 陈杰, 等. 自主设计3D打印截肝导板在肝癌切除手术中的初步应用[J].中华肝胆外科杂志, 2019, 25(9):641-644.
|
[12] |
Wang K, Guo WX, Chen MS, et al. Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis[J]. Medicine, 2016, 95(11):e3015.
|
[13] |
Finn RS, Ikeda M, Zhu AX, et al. Phase Ⅰb study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma[J]. J Clin Oncol, 2020, 38(26):2960-2970.
|
[14] |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 中华消化外科杂志, 2020, 19(1):1-20.
|
[15] |
Lau WY, Lai EC. Salvage surgery following downstaging of unresectable hepatocellular carcinoma-a strategy to increase resectability[J]. Ann Surg Oncol, 2007, 14(12):3301-3309.
|
[16] |
中国抗癌协会肝癌专业委员会转化治疗协作组. 肝癌转化治疗中国专家共识(2021版)[J]. 中华消化外科杂志, 2021, 20(6):600-616.
|
[17] |
Alrashidi I, Chu HH, Kim JH, et al. Combined chemoembolization and radiotherapy versus chemoembolization alone for hepatocellular carcinoma invading the hepatic vein or inferior vena cava[J]. Cardiovasc Intervent Radiol, 2021, 44(7):1060-1069.
|
[18] |
Lee WH, Byun HK, Choi JS, et al. Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria[J]. Radiother Oncol, 2020(152):1-7.
|
[19] |
Lyu N, Kong Y, Mu L, et al. Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1):60-69.
|
[20] |
Goto Y, Hisaka T, Sakai H, et al. Salvage surgery for initially unresectable locally advanced hepatocellular carcinoma downstaged by hepatic arterial infusion chemotherapy[J]. Anticancer Res, 2020, 40(8):4773-4777.
|
[21] |
Irtan S, Chopin-Laly X, Ronot M, et al. Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection[J]. Liver Int, 2011, 31(5):740-743.
|
[22] |
赵頔, 叶进冬, 李华丽, 等. 肝脏三维可视化重建技术在儿童复杂肝母细胞瘤肝切除术中的应用价值[J]. 临床肝胆病杂志, 2021, 37(9):2130-2135.
|